$Inari Medical(NARI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-21-026536 Act: 34 Size: 8 MB 网页链接
$Inari Medical(NARI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-21-026530 Act: 34 Size: 292 KB 网页链接
$Inari Medical(NARI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-21-003316 Size: 20 KB 网页链接
$Inari Medical(NARI)$ 内部交易: 2021-04-27,Chief Medical Officer,Tu Thomas ,卖出,5000普通股, $113.12
$Inari Medical(NARI)$ 内部交易: 2021-04-27,Chief Medical Officer,Tu Thomas ,期权,5000普通股, $0.05
$Inari Medical(NARI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-21-003041 Size: 14 KB 网页链接
$Inari Medical(NARI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-133809 Act: 34 Size: 157 KB 网页链接
$Inari Medical(NARI)$ 内部交易: 2021-04-19,COO,Hykes Andrew ,卖出,9000普通股, $103.18
$Inari Medical(NARI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001562180-21-002900 Size: 12 KB 网页链接
$Inari Medical(NARI)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-21-119339 Act: 34 Size: 667 KB 网页链接